Ignite Creation Date:
2025-12-24 @ 10:18 PM
Ignite Modification Date:
2025-12-28 @ 1:33 PM
Study NCT ID:
NCT05053035
Status:
TERMINATED
Last Update Posted:
2025-06-18
First Post:
2021-09-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 2 Study to Evaluate AL001 in C9orf72-Associated ALS
Sponsor:
Alector Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
AL001-ALS-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None